基因组景观和高级甲状腺癌的临床特征:日本的一项国家数据库研究
Soji Toda1,2, Yukihiko Hiroshima3,4, Hiroyuki Iwasaki1
1Department of Endocrine Surgery, Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
The Journal of clinical endocrinology and metabolism
|April 17, 2024
概括
TP53遗传变化预测晚期分化甲状腺癌的存活率较差. 在晚期甲状腺癌患者中,伦瓦提尼布治疗失效时间在各种遗传特征中相似.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期甲状腺癌接受药物治疗的基因组变化的预后影响仍然在很大程度上未被描述.
- 了解这些关系对于个性化治疗策略至关重要.
研究的目的:
- 研究特定遗传变化与治疗结果之间的关联,包括治疗失败的时间和整体存活率.
- 评估在需要全身治疗的晚期甲状腺癌中遗传特征的预后价值.
主要方法:
- 来自日本国家数据库的552例晚期甲状腺癌病例的回顾性分析.
- 分析了包括TERT促销物,BRAF,TP53,RAS和各种融合在内的基因组变化.
- 结果,如治疗失败的时间和整体存活率,与遗传特征和治疗方案 (主要是lenvatinib) 相比进行了评估.
主要成果:
- 鉴定出TP53的变化是差异化和差异化甲状腺癌总生存率较差的独立预测因子.
- 不同的基因突变档案 (例如,BRAF,RAS) 中没有观察到伦瓦替尼治疗失败的时间有显著差异.
- 在形甲状腺癌中,没有与整体生存结果相关的特定遗传变化.
结论:
- 大约62.7%的晚期甲状腺癌患有与向治疗相关的遗传异常.
- TP53突变状态是差异化甲状腺癌总生存时间的显著预后生物标志物.
- 目前的药物治疗,如伦瓦提尼布,无论常见的遗传改变,都显示出一致的疗效,这表明更广泛的适用性.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


